SLN
Silence Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.74 / 10
Netural
Scoring 3.74/10 technically, the instrument displays challenging technical structure. Positive contributions from MACD Death Cross are diluted by negative influences from MACD Golden Cross, Long Lower Shadow, and Long Upper Shadow. Technical judgment: cautious.
Analysis Checks(1/4)
Long Lower Shadow
Score3.47/10
Win Rate51.16%
Hist. Signals86
Avg Return0.59%
Score3.47/10
Win Rate51.16%
Hist. Signals86
Avg Return0.59%
MACD Death Cross
Score6.65/10
Win Rate62.50%
Hist. Signals8
Avg Return1.02%
Score6.65/10
Win Rate62.50%
Hist. Signals8
Avg Return1.02%
Long Upper Shadow
Score3.83/10
Win Rate50.65%
Hist. Signals77
Avg Return1.46%
Score3.83/10
Win Rate50.65%
Hist. Signals77
Avg Return1.46%
MACD Golden Cross
Score1/10
Win Rate37.50%
Hist. Signals8
Avg Return-2.77%
Score1/10
Win Rate37.50%
Hist. Signals8
Avg Return-2.77%
Long Lower Shadow
Score3.47/10
Win Rate51.16%
Hist. Signals86
Avg Return0.59%
Score3.47/10
Win Rate51.16%
Hist. Signals86
Avg Return0.59%
Long Upper Shadow
Score3.83/10
Win Rate50.65%
Hist. Signals77
Avg Return1.46%
Score3.83/10
Win Rate50.65%
Hist. Signals77
Avg Return1.46%
MACD Death Cross
Score6.65/10
Win Rate62.50%
Hist. Signals8
Avg Return1.02%
Score6.65/10
Win Rate62.50%
Hist. Signals8
Avg Return1.02%
MACD Golden Cross
Score1/10
Win Rate37.50%
Hist. Signals8
Avg Return-2.77%
Score1/10
Win Rate37.50%
Hist. Signals8
Avg Return-2.77%
Technical Analysis of SLN?
- SLN presents a Netural setup with a Technical Score of 3.74/10. Key technical indicators highlight an RSI of 38.93 and a MACD of -0.10, with the trend anchored by the 50-Day SMA at 5.90. Traders should monitor key support at 4.26 and resistance at 4.88.
